Candida glabrata is the second most reported Candida species causing candidiasis next only to Candida albicans. Biofilm formation by C. glabrata accelerates pathogenicity, so understanding conditions for biofilm formation in relevant polystyrene polymers is essential. Determining optimum conditions for biofilm formation using one variable at a time (OVAT) is laborious and inaccurate. Therefore, mathematical modelling for design of experiments to optimize conditions for biofilm formation in Candida species was undertaken. In this study, a simple and robust statistical method, response surface methodology (RSM) was used to optimize independent variables like temperature, incubation period, media pH, shaker speed and inoculum density. Biofilm forming conditions were optimized and compared for two important local clinical isolates and one standard culture on 96 well polystyrene microtiter plates. Biofilm was quantified by different methods, like XTT for cell viability, crystal violet for biofilm, calcofluor white, and wet and dry weight measurements for cell mass. Quantification of cell viability and biofilm indicated heterogeneity among the three cultures. The results revealed an important finding that foetal bovine serum (FBS) does not significantly affect biofilm formation in vitro. This simple high throughput method for optimization and quantification of Candida biofilm has relevance for applications in rapid screening of anti-Candida biologics and therapeutic solutions while advancing control measures in polystyrene carriers in hospital settings.
Gupta P, Rastogi A, Joshi S, Bhardwaj A, Misra K, Kumar N, Indian J. Pharma. Sci., 80, 949, 2018
Rodrigues CF, Correia A, Vilanova M, Henriques M, J. Clin. Med., 8, 142, 2019
Alves R, Kastora SL, Gomes-Gonçalves A, Azevedo N, Rodrigues CF, Silva S, Demuyser L, Van Dijck P, Casal M, Brown AJ, Henriques M, npj Biofilms Microbiomes, 6, 1, 2020
Rodrigues C, Henriques M, Genes, 9, 205, 2018
Olson ML, Jayaraman A, Kao KC, Appl. Environ. Microbiol., 84, e02769-1, 2018
Kaur B, Kumar B, Garg N, Kaur N, BioMed. Res. Int., 2015, Article ID 536745 (2015).
Almeida DG, da Silva RCFS, Luna JM, Rufino RD, Santos VA, Sarubbo LA, Front. Microbiol., 8, 157, 2017
Myers RH, Montgomery DC, Vining GGG, Borror CM, Kowalski SM, J. Qual. Technol., 36, 53, 2004
Leonhard M, Zatorska B, Moser D, Schneider-Stickler B, Biomed Res. Int., 2019, Article ID 8051270 (2019).
Maresova L, Sychrova H, BioTechn., 43, 667, 2007
Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, Minor L, Cell viability assays guidance manual [Internet]. Eli Lilly & Company and the National Centre for Advancing Translational Sciences, Bethesda (MD) (2016).
Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP, J. Clin. Microbiol., 4, 2961, 2003
Xavier BJ, Foster RK, PNAS, 104, 876, 2007
Nett JE, Cain MT, Crawford K, Andes DR, J. Clin. Microbiol., 49, 1426, 2011
Cavalieri D, Di Paola M, Rizzetto L, Tocci N, De Filippo C, Lionetti P, Ardizzoni A, Colombar B, Paulone S, Gut IG, Berna L, Gut M, Blanc J, Kapushesky M, Pericolini E, Blasi E, Peppoloni S, Front. Immunol., 8, 1997, 2018
Brown JL, Delaney C, Short B, Butcher MC, Mckloud E, Williams C, Kean R, Ramage G, mSphere, 5, e00371-2, 2020
Kean R, Delaney C, Rajendran R, Sherry L, Metcalfe R, Thomas R, McLean W, Williams C, Ramage G, J. Fungi, 4, 12, 2018